Search Results - Matthew A. Arquette
- Showing 1 - 3 results of 3
-
1
Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck by Roy S. Herbst, Matthew A. Arquette, Dong M. Shin, Karel A. Dicke, Everett E. Vokes, N. Azarnia, Waun Ki Hong, Merrill S. Kies
Published 2005Artigo -
2
A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing by Paula M. Fracasso, Howard A. Burris, Matthew A. Arquette, Ramaswamy Govindan, Feng Gao, L. Wright, Sherry A. Goodner, F. Anthony Greco, Suzanne F. Jones, Noel T. Willcut, Catherine Chodkiewicz, Amit Pathak, Gregory M. Springett, George R. Simon, Daniel M. Sullivan, Raphaël Marcelpoil, S. Mayfield, David Mauro, Christopher R. Garrett
Published 2007Artigo -
3
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies by Paula M. Fracasso, Kerry J. Williams, Ronald C. Chen, Joel Picus, X. Cynthia, Matthew J. Ellis, Benjamin Tan, Timothy Pluard, Douglas R. Adkins, Michael Naughton, Janet S. Rader, Matthew A. Arquette, James W. Fleshman, Allison Creekmore, Sherry A. Goodner, L. Wright, Zhanfang Guo, Christine E. Ryan, Tao Yu, Eliane Maria Azevedo Soares, Shi-Rong Cai, Lin Li, Janet Dancey, Michelle A. Rudek, Howard L. McLeod, Helen Piwnica‐Worms
Published 2010Artigo